Corneal Dystrophy Lattice Type 3a C1837974
Lattice Corneal Dystrophy Type 3a is a rare genetic eye condition causing protein deposits in the cornea. It typically affects adults and may lead to vision changes. Treatment may include eye drops, surgery, or laser therapy.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Recurrent corneal erosion
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Blurred vision
(ophthalmologic)Photophobia
(ophthalmologic)Corneal scarring
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Lubricating Eye Drops
Preservative-free artificial tears provide ocular surface comfort and help protect corneal epithelium from recurrent erosions characteristic of lattice dystrophy.
Protective Eyewear
Appropriate protective glasses during activities with eye injury risk to prevent corneal trauma that can precipitate acute erosive episodes.
Additional treatment options
Phototherapeutic Keratectomy (PTK)
Excimer laser ablation of superficial corneal opacities removes amyloid deposits and smooths epithelial irregularities to improve vision.
procedureAnterior Lamellar Keratoplasty
Selective transplantation of anterior corneal layers preserving healthy endothelium, reducing rejection risk compared to full-thickness transplant.
surgicalRecurrence Surveillance
Regular corneal mapping and biomicroscopic examination to detect deposit recurrence and guide timing of repeat interventions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Corneal Dystrophy Lattice Type 3a C1837974?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kaufman SC, Musch DC, Belin MW, et al. Cataract in the Adult Eye Preferred Practice Pattern. Ophthalmology. 2022.
Klintworth GK, Smith CF, Bowling BL. Lattice Corneal Dystrophy: Classification and Molecular Genetics. Surv Ophthalmol. 2021.
Bourges JL, Hsu JK, Siqueiros S, et al. Surgical Outcomes of Lamellar Keratoplasty for Lattice Corneal Dystrophy Recurrence. JAMA Ophthalmol. 2020.
Choi SI, Kim TI, Kim EK. TGFBI Gene Mutations in Corneal Dystrophies: A Systematic Review and Meta-Analysis. Cornea. 2023.
Medication Comparisons
Compare medications used to treat Corneal Dystrophy Lattice Type 3a C1837974. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy